PM Pharma ApS: Financial statements 2024
CVR: 42988197
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PM Pharma ApS (CVR 42988197) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,320,571 and a net result of DKK 6,341 compared with DKK 27,036 the year before. That is an increase of 32.9% compared with the year before. Equity in the 2024 report amounted to DKK 170,990. The solvency ratio was 16.6%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 3,320,571
- Profit/Loss
- DKK 6,341
- Equity
- DKK 170,990
- Total Assets
- DKK 1,031,609
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 3.3 mio. | 6 t. | 171 t. | 3 |
| 2023 | - | 2.5 mio. | 27 t. | 165 t. | 3 |
| 2022 | - | 1 mio. | 188 t. | 228 t. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PM Pharma ApS has published its annual report for 2023. Gross profit came to DKK 2,498,090, and the net result was DKK 27,036.
About PM Pharma ApS
PM Pharma ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2022. The company is registered under the industry Installation af industrimaskiner og -udstyr. The management consists of Patrick Munck. The company is owned by PM Engineering ApS. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 3,220,588 and a net result of DKK -19,580 compared with DKK 6,341 the year before. Equity in the 2025 report amounted to DKK 151,479.